Minneapolis Clinical Trials
Flow Study
Purpose: to evaluate the safety and tolerability of a potential new drug to treat drug resistant critical infections.
16 nights
1 visits
Participate in a clinical study of a potential treatment for drug resistant critical infections.
This study has 1 screening appointment, 1 inpatient stays of 17 days and 16 nights.
Reimbursement for study participation will be provided for time and travel of up to $8,360.
Participants must be comfortable with multiple IV infusions.
All doses given will be administered by IV infusion over 3 hours each. Over the trial, 3 doses will be given.
This study has been reviewed by an Institutional Review Board.
Call 612-315-6490 to discuss your eligibility today!
Eligibility
Age: 18-55
BMI: 18.5-32 kg/m2
Medications: No prescription medications allowed for 14 days prior to Day 1
Smoking Status: Must be a non-smoker or smoke less than 5 packs/week of cigarettes. Any smokers must refrain during the study.
Dose Administration: intravenous infusion, 3 doses will be given
Compensation: Up to $8,360